Logo image of REPL

REPLIMUNE GROUP INC (REPL) Stock Fundamental Analysis

USA - NASDAQ:REPL - US76029N1063 - Common Stock

9.73 USD
-0.52 (-5.07%)
Last: 10/31/2025, 8:11:19 PM
9.71 USD
-0.02 (-0.21%)
After Hours: 10/31/2025, 8:11:19 PM
Fundamental Rating

2

Taking everything into account, REPL scores 2 out of 10 in our fundamental rating. REPL was compared to 534 industry peers in the Biotechnology industry. REPL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. REPL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

REPL had negative earnings in the past year.
In the past year REPL has reported a negative cash flow from operations.
In the past 5 years REPL always reported negative net income.
REPL had a negative operating cash flow in each of the past 5 years.
REPL Yearly Net Income VS EBIT VS OCF VS FCFREPL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M -250M

1.2 Ratios

Looking at the Return On Assets, with a value of -59.68%, REPL is in line with its industry, outperforming 43.45% of the companies in the same industry.
Looking at the Return On Equity, with a value of -83.22%, REPL is in line with its industry, outperforming 51.31% of the companies in the same industry.
Industry RankSector Rank
ROA -59.68%
ROE -83.22%
ROIC N/A
ROA(3y)-38.68%
ROA(5y)-31.31%
ROE(3y)-49.49%
ROE(5y)-38.68%
ROIC(3y)N/A
ROIC(5y)N/A
REPL Yearly ROA, ROE, ROICREPL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40 -50

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for REPL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
REPL Yearly Profit, Operating, Gross MarginsREPL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for REPL has been increased compared to 1 year ago.
Compared to 5 years ago, REPL has more shares outstanding
Compared to 1 year ago, REPL has an improved debt to assets ratio.
REPL Yearly Shares OutstandingREPL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
REPL Yearly Total Debt VS Total AssetsREPL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -0.82, we must say that REPL is in the distress zone and has some risk of bankruptcy.
REPL's Altman-Z score of -0.82 is in line compared to the rest of the industry. REPL outperforms 55.24% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that REPL is not too dependend on debt financing.
The Debt to Equity ratio of REPL (0.21) is worse than 67.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z -0.82
ROIC/WACCN/A
WACCN/A
REPL Yearly LT Debt VS Equity VS FCFREPL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

REPL has a Current Ratio of 6.94. This indicates that REPL is financially healthy and has no problem in meeting its short term obligations.
REPL has a Current ratio of 6.94. This is in the better half of the industry: REPL outperforms 69.10% of its industry peers.
REPL has a Quick Ratio of 6.94. This indicates that REPL is financially healthy and has no problem in meeting its short term obligations.
REPL's Quick ratio of 6.94 is fine compared to the rest of the industry. REPL outperforms 69.29% of its industry peers.
Industry RankSector Rank
Current Ratio 6.94
Quick Ratio 6.94
REPL Yearly Current Assets VS Current LiabilitesREPL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.92% over the past year.
EPS 1Y (TTM)0.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

REPL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.49% yearly.
The Revenue is expected to grow by 136.60% on average over the next years. This is a very strong growth
EPS Next Y-6.24%
EPS Next 2Y15.3%
EPS Next 3Y12.38%
EPS Next 5Y13.49%
Revenue Next Year-100%
Revenue Next 2Y114.33%
Revenue Next 3Y138.56%
Revenue Next 5Y136.6%

3.3 Evolution

REPL Yearly Revenue VS EstimatesREPL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2025 2027 2028 2029 2030 2031 2032 100M 200M 300M
REPL Yearly EPS VS EstimatesREPL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

REPL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for REPL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
REPL Price Earnings VS Forward Price EarningsREPL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
REPL Per share dataREPL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

REPL's earnings are expected to grow with 12.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.3%
EPS Next 3Y12.38%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for REPL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REPLIMUNE GROUP INC

NASDAQ:REPL (10/31/2025, 8:11:19 PM)

After market: 9.71 -0.02 (-0.21%)

9.73

-0.52 (-5.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners105%
Inst Owner Change0.01%
Ins Owners2%
Ins Owner Change-0.38%
Market Cap759.52M
Revenue(TTM)N/A
Net Income(TTM)-280218000
Analysts54.29
Price Target10.84 (11.41%)
Short Float %24.1%
Short Ratio3.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11.09%
Min EPS beat(2)-15.38%
Max EPS beat(2)-6.81%
EPS beat(4)1
Avg EPS beat(4)-6.04%
Min EPS beat(4)-15.38%
Max EPS beat(4)12.93%
EPS beat(8)3
Avg EPS beat(8)0.01%
EPS beat(12)6
Avg EPS beat(12)1.38%
EPS beat(16)7
Avg EPS beat(16)-0.09%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)48.75%
PT rev (3m)-53.22%
EPS NQ rev (1m)5.78%
EPS NQ rev (3m)-7.11%
EPS NY rev (1m)5.68%
EPS NY rev (3m)-5.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.26
P/tB 2.26
EV/EBITDA N/A
EPS(TTM)-3.24
EYN/A
EPS(NY)-2.06
Fwd EYN/A
FCF(TTM)-2.92
FCFYN/A
OCF(TTM)-2.82
OCFYN/A
SpS0
BVpS4.31
TBVpS4.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -59.68%
ROE -83.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-38.68%
ROA(5y)-31.31%
ROE(3y)-49.49%
ROE(5y)-38.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 213.19%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.94
Quick Ratio 6.94
Altman-Z -0.82
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)165.62%
Cap/Depr(5y)149.09%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.79%
EPS Next Y-6.24%
EPS Next 2Y15.3%
EPS Next 3Y12.38%
EPS Next 5Y13.49%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y114.33%
Revenue Next 3Y138.56%
Revenue Next 5Y136.6%
EBIT growth 1Y-24.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-38.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-57.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.72%
OCF growth 3YN/A
OCF growth 5YN/A

REPLIMUNE GROUP INC / REPL FAQ

What is the fundamental rating for REPL stock?

ChartMill assigns a fundamental rating of 2 / 10 to REPL.


Can you provide the valuation status for REPLIMUNE GROUP INC?

ChartMill assigns a valuation rating of 0 / 10 to REPLIMUNE GROUP INC (REPL). This can be considered as Overvalued.


What is the profitability of REPL stock?

REPLIMUNE GROUP INC (REPL) has a profitability rating of 1 / 10.


What is the expected EPS growth for REPLIMUNE GROUP INC (REPL) stock?

The Earnings per Share (EPS) of REPLIMUNE GROUP INC (REPL) is expected to decline by -6.24% in the next year.